Potential explanations for increasing methylphenidate use in children and adolescents with attention-deficit/hyperactivity disorder in Germany from 2004 to 2013

I Langner, U Haug, O Scholle… - Journal of Clinical …, 2019 - journals.lww.com
Background Despite a decreasing population of children and adolescents, the cumulative
total amount of dispensed methylphenidate (MPH), the first-choice treatment of attention …

Drug treatment patterns of attention-deficit/hyperactivity disorder in children and adolescents in Germany: results from a large population-based cohort study

E Garbe, RT Mikolajczyk, T Banaschewski… - Journal of child and …, 2012 - liebertpub.com
Objective: Despite a substantial increase in total methylphenidate (MPH) prescriptions in
Germany over the last 20 years, and the introduction of modified release MPH (MR MPH) …

Comorbidities in ADHD children treated with methylphenidate: a database study

AA Kraut, I Langner, C Lindemann, T Banaschewski… - BMC psychiatry, 2013 - Springer
Background Methylphenidate (MPH) is the most common drug treatment of attention
deficit/hyperactivity disorder (ADHD) in children. Treatment with MPH is contraindicated in …

[HTML][HTML] The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the …

I Schubert, I Köster, G Lehmkuhl - Deutsches Ärzteblatt …, 2010 - ncbi.nlm.nih.gov
Background The goal of this study is to assess changes in the prevalence of attention-
deficit/hyperactivity disorder (ADHD) and methylphenidate prescriptions over the period …

Patterns and profiles of methylphenidate use both in children and adults

V Pauly, E Frauger, M Lepelley… - British journal of …, 2018 - Wiley Online Library
Aim The aim of the present study was to characterize patterns of use of methylphenidate
(MPH), a prescription stimulant medication recommended in the treatment of attention deficit …

Prevalence of methylphenidate use among Israeli children 1998–2004

S Vinker, R Vinker, A Elhayany - Clinical drug investigation, 2006 - Springer
Background: Use of methylphenidate for the treatment of attention-deficit hyperactivity
disorder (ADHD) has increased throughout the world in the past decade. In Israel, as …

Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud …

C Gumy, T Huissoud… - Journal of attention …, 2010 - journals.sagepub.com
Objective: Methylphenidate is prescribed for children and adolescents to treat ADHD. As in
many Western countries, the increase in methylphenidate consumption is a public concern …

Trends in incidence and characteristics of children, adolescents, and adults initiating immediate-or extended-release methylphenidate or atomoxetine in the …

E van den Ban, P Souverein, H Swaab… - Journal of Child and …, 2010 - liebertpub.com
Abstract Background: Previous Dutch studies showed increasing psychostimulant use,
especially methylphenidate immediate-release (MPH-IR), between 1995 and 2003. In 2003 …

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder

M Rösler, R Fischer, R Ammer, C Ose, W Retz… - European archives of …, 2009 - Springer
Introduction Attention-deficit/hyperactivity disorder (ADHD) affects many adults who had
ADHD in childhood. Although stimulants and methylphenidate in particular are a common off …

Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic …

J Park, DY Lee, C Kim, YH Lee, SJ Yang, S Lee… - Child and adolescent …, 2022 - Springer
Background Methylphenidate (MPH) is the most frequently prescribed medication for the
treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long …